New Zealand markets closed

Bio-Rad Laboratories, Inc. (BIO)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
480.29+12.77 (+2.73%)
At close: 04:04PM EDT
480.29 +0.71 (+0.15%)
After hours: 04:08PM EDT
Show:
Income statement
Cash flow
Annual

Balance sheet

All numbers in thousands
Breakdown
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Assets
Current assets
Cash
Cash and cash equivalents
434,215
470,783
662,205
660,672
Other short-term investments
1,356,457
399,135
328,913
453,973
Total cash
1,790,672
869,918
991,118
1,114,645
Net receivables
494,645
423,537
419,424
392,672
Inventory
719,316
572,239
622,253
554,007
Other current assets
23,604
10,089
10,859
10,940
Total current assets
3,157,976
1,989,088
2,139,835
2,180,155
Non-current assets
Property, plant and equipment
Gross property, plant and equipment
1,688,972
1,693,366
1,654,897
1,584,040
Accumulated depreciation
-1,009,408
-997,616
-961,390
-882,833
Net property, plant and equipment
679,564
695,750
693,507
701,207
Equity and other investments
8,830,892
14,387,006
9,561,140
4,638,205
Goodwill
406,500
347,300
291,900
264,100
Intangible assets
332,100
253,900
199,500
145,500
Other long-term assets
94,599
102,669
86,723
79,636
Total non-current assets
10,343,655
15,786,625
10,832,770
5,828,648
Total assets
13,501,666
17,775,795
12,972,618
8,008,859
Liabilities and stockholders' equity
Liabilities
Current liabilities
Current debt
465
489
1,300
425,700
Accounts payable
135,041
141,941
139,451
107,014
Taxes payable
11,929
10,319
23,282
8,763
Accrued liabilities
194,790
276,986
222,875
180,084
Deferred revenues
52,211
50,852
42,468
33,735
Other current liabilities
117,437
127,925
131,100
86,812
Total current liabilities
568,708
680,938
631,536
905,495
Non-current liabilities
Long-term debt
1,197,716
10,514
1,300
2,400
Deferred tax liabilities
1,770,481
3,059,080
2,076,785
997,787
Other long-term liabilities
195,912
182,205
196,929
160,902
Total non-current liabilities
3,317,706
3,427,723
2,461,142
1,348,307
Total liabilities
3,886,414
4,108,661
3,092,678
2,253,802
Stockholders' equity
Common stock
3
3
3
3
Retained earnings
9,898,203
13,507,241
9,268,012
5,470,779
Accumulated other comprehensive income
-466,822
-175,553
282,456
-87,348
Total stockholders' equity
9,615,252
13,667,134
9,879,940
5,755,057
Total liabilities and stockholders' equity
13,501,666
17,775,795
12,972,618
8,008,859